Supplementary prescribing

Early experiences of pharmacists in Great Britain

Johnson George, Dorothy J. McCaig, Christine Margaret Bond, I. T. Scott Cunningham, Lesley Diack, Anne M. Watson, Derek C. Stewart

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

BACKGROUND: Pharmacists in Great Britain can undertake supplementary prescribing (SP) after training at a higher education institution and completing a "period of learning in practice" in accordance with the Royal Pharmaceutical Society of Great Britain (RPSGB) curriculum.
OBJECTIVE: To explore SP pharmacists' early experiences of prescribing and their perceptions of the prescribing course.
METHODS: A questionnaire was mailed to all RPSGB prescribers (N = 518, on June 1, 2005; 30 used in pilot questionnaire). Predictors of pharmacists starting to practice SP were identified in univariate analysis, and significant variables were further tested in multivariate analysis.
RESULTS: The respondents (n = 401; 82.2%) were mainly female (270; 67.3%), had more than 20 years' experience as a pharmacist (123; 30.7%), worked in hospital settings (160; 39.9%), and focused on cardiovascular conditions (143; 35.7%) during their period of learning in practice. The median course satisfaction score, on a scale of 3 to 15 (lowest to highest), was 10. Practicing SP was self-reported by 195 (48.6%) respondents, 154 (79%) of whom had written a prescription. Ninety (58.4%) of the first prescriptions were written in primary care settings. Better patient management was regarded as the major benefit by 139 (71.3%) of those engaged in SP, while funding issues were identified by 71 (36.4%) as major barriers in implementing the practice. Lack of organizational recognition of SP was the main reason given (37; 18%) for those not commencing the practice. Independent predictors of those practicing SP included a longer time since registering as prescriber (p < 0.001); confidence of pharmacists in their prescribing abilities (p < 0.001); practicing in a setting other than community pharmacy (p = 0.001); and training in cardiovascular conditions or multiple conditions during the period of learning in practice (p = 0.005).
CONCLUSIONS: Pharmacists have made progress in implementing SP, which is perceived by pharmacist prescribers as beneficial for both patients and themselves. Pharmacists need more support in terms of infrastructure and integration into the healthcare team to overcome some of the barriers to implementing SP.

Original languageEnglish
Pages (from-to)1843-1850
Number of pages8
JournalThe Annals of Pharmacotherapy
Volume40
Issue number10
Early online date12 Sep 2006
DOIs
Publication statusPublished - 2006

Keywords

  • Britain
  • pharmacist prescribing
  • supplementary prescribing
  • records

Cite this

George, J., McCaig, D. J., Bond, C. M., Cunningham, I. T. S., Diack, L., Watson, A. M., & Stewart, D. C. (2006). Supplementary prescribing: Early experiences of pharmacists in Great Britain. The Annals of Pharmacotherapy, 40(10), 1843-1850. https://doi.org/10.1345/aph.1H227

Supplementary prescribing : Early experiences of pharmacists in Great Britain. / George, Johnson; McCaig, Dorothy J.; Bond, Christine Margaret; Cunningham, I. T. Scott; Diack, Lesley; Watson, Anne M.; Stewart, Derek C.

In: The Annals of Pharmacotherapy, Vol. 40, No. 10, 2006, p. 1843-1850.

Research output: Contribution to journalArticle

George, J, McCaig, DJ, Bond, CM, Cunningham, ITS, Diack, L, Watson, AM & Stewart, DC 2006, 'Supplementary prescribing: Early experiences of pharmacists in Great Britain', The Annals of Pharmacotherapy, vol. 40, no. 10, pp. 1843-1850. https://doi.org/10.1345/aph.1H227
George, Johnson ; McCaig, Dorothy J. ; Bond, Christine Margaret ; Cunningham, I. T. Scott ; Diack, Lesley ; Watson, Anne M. ; Stewart, Derek C. / Supplementary prescribing : Early experiences of pharmacists in Great Britain. In: The Annals of Pharmacotherapy. 2006 ; Vol. 40, No. 10. pp. 1843-1850.
@article{15d310eccc0b4082bc1d4a5ba482fa26,
title = "Supplementary prescribing: Early experiences of pharmacists in Great Britain",
abstract = "BACKGROUND: Pharmacists in Great Britain can undertake supplementary prescribing (SP) after training at a higher education institution and completing a {"}period of learning in practice{"} in accordance with the Royal Pharmaceutical Society of Great Britain (RPSGB) curriculum. OBJECTIVE: To explore SP pharmacists' early experiences of prescribing and their perceptions of the prescribing course. METHODS: A questionnaire was mailed to all RPSGB prescribers (N = 518, on June 1, 2005; 30 used in pilot questionnaire). Predictors of pharmacists starting to practice SP were identified in univariate analysis, and significant variables were further tested in multivariate analysis. RESULTS: The respondents (n = 401; 82.2{\%}) were mainly female (270; 67.3{\%}), had more than 20 years' experience as a pharmacist (123; 30.7{\%}), worked in hospital settings (160; 39.9{\%}), and focused on cardiovascular conditions (143; 35.7{\%}) during their period of learning in practice. The median course satisfaction score, on a scale of 3 to 15 (lowest to highest), was 10. Practicing SP was self-reported by 195 (48.6{\%}) respondents, 154 (79{\%}) of whom had written a prescription. Ninety (58.4{\%}) of the first prescriptions were written in primary care settings. Better patient management was regarded as the major benefit by 139 (71.3{\%}) of those engaged in SP, while funding issues were identified by 71 (36.4{\%}) as major barriers in implementing the practice. Lack of organizational recognition of SP was the main reason given (37; 18{\%}) for those not commencing the practice. Independent predictors of those practicing SP included a longer time since registering as prescriber (p < 0.001); confidence of pharmacists in their prescribing abilities (p < 0.001); practicing in a setting other than community pharmacy (p = 0.001); and training in cardiovascular conditions or multiple conditions during the period of learning in practice (p = 0.005). CONCLUSIONS: Pharmacists have made progress in implementing SP, which is perceived by pharmacist prescribers as beneficial for both patients and themselves. Pharmacists need more support in terms of infrastructure and integration into the healthcare team to overcome some of the barriers to implementing SP.",
keywords = "Britain, pharmacist prescribing, supplementary prescribing, records",
author = "Johnson George and McCaig, {Dorothy J.} and Bond, {Christine Margaret} and Cunningham, {I. T. Scott} and Lesley Diack and Watson, {Anne M.} and Stewart, {Derek C.}",
year = "2006",
doi = "10.1345/aph.1H227",
language = "English",
volume = "40",
pages = "1843--1850",
journal = "The Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "10",

}

TY - JOUR

T1 - Supplementary prescribing

T2 - Early experiences of pharmacists in Great Britain

AU - George, Johnson

AU - McCaig, Dorothy J.

AU - Bond, Christine Margaret

AU - Cunningham, I. T. Scott

AU - Diack, Lesley

AU - Watson, Anne M.

AU - Stewart, Derek C.

PY - 2006

Y1 - 2006

N2 - BACKGROUND: Pharmacists in Great Britain can undertake supplementary prescribing (SP) after training at a higher education institution and completing a "period of learning in practice" in accordance with the Royal Pharmaceutical Society of Great Britain (RPSGB) curriculum. OBJECTIVE: To explore SP pharmacists' early experiences of prescribing and their perceptions of the prescribing course. METHODS: A questionnaire was mailed to all RPSGB prescribers (N = 518, on June 1, 2005; 30 used in pilot questionnaire). Predictors of pharmacists starting to practice SP were identified in univariate analysis, and significant variables were further tested in multivariate analysis. RESULTS: The respondents (n = 401; 82.2%) were mainly female (270; 67.3%), had more than 20 years' experience as a pharmacist (123; 30.7%), worked in hospital settings (160; 39.9%), and focused on cardiovascular conditions (143; 35.7%) during their period of learning in practice. The median course satisfaction score, on a scale of 3 to 15 (lowest to highest), was 10. Practicing SP was self-reported by 195 (48.6%) respondents, 154 (79%) of whom had written a prescription. Ninety (58.4%) of the first prescriptions were written in primary care settings. Better patient management was regarded as the major benefit by 139 (71.3%) of those engaged in SP, while funding issues were identified by 71 (36.4%) as major barriers in implementing the practice. Lack of organizational recognition of SP was the main reason given (37; 18%) for those not commencing the practice. Independent predictors of those practicing SP included a longer time since registering as prescriber (p < 0.001); confidence of pharmacists in their prescribing abilities (p < 0.001); practicing in a setting other than community pharmacy (p = 0.001); and training in cardiovascular conditions or multiple conditions during the period of learning in practice (p = 0.005). CONCLUSIONS: Pharmacists have made progress in implementing SP, which is perceived by pharmacist prescribers as beneficial for both patients and themselves. Pharmacists need more support in terms of infrastructure and integration into the healthcare team to overcome some of the barriers to implementing SP.

AB - BACKGROUND: Pharmacists in Great Britain can undertake supplementary prescribing (SP) after training at a higher education institution and completing a "period of learning in practice" in accordance with the Royal Pharmaceutical Society of Great Britain (RPSGB) curriculum. OBJECTIVE: To explore SP pharmacists' early experiences of prescribing and their perceptions of the prescribing course. METHODS: A questionnaire was mailed to all RPSGB prescribers (N = 518, on June 1, 2005; 30 used in pilot questionnaire). Predictors of pharmacists starting to practice SP were identified in univariate analysis, and significant variables were further tested in multivariate analysis. RESULTS: The respondents (n = 401; 82.2%) were mainly female (270; 67.3%), had more than 20 years' experience as a pharmacist (123; 30.7%), worked in hospital settings (160; 39.9%), and focused on cardiovascular conditions (143; 35.7%) during their period of learning in practice. The median course satisfaction score, on a scale of 3 to 15 (lowest to highest), was 10. Practicing SP was self-reported by 195 (48.6%) respondents, 154 (79%) of whom had written a prescription. Ninety (58.4%) of the first prescriptions were written in primary care settings. Better patient management was regarded as the major benefit by 139 (71.3%) of those engaged in SP, while funding issues were identified by 71 (36.4%) as major barriers in implementing the practice. Lack of organizational recognition of SP was the main reason given (37; 18%) for those not commencing the practice. Independent predictors of those practicing SP included a longer time since registering as prescriber (p < 0.001); confidence of pharmacists in their prescribing abilities (p < 0.001); practicing in a setting other than community pharmacy (p = 0.001); and training in cardiovascular conditions or multiple conditions during the period of learning in practice (p = 0.005). CONCLUSIONS: Pharmacists have made progress in implementing SP, which is perceived by pharmacist prescribers as beneficial for both patients and themselves. Pharmacists need more support in terms of infrastructure and integration into the healthcare team to overcome some of the barriers to implementing SP.

KW - Britain

KW - pharmacist prescribing

KW - supplementary prescribing

KW - records

U2 - 10.1345/aph.1H227

DO - 10.1345/aph.1H227

M3 - Article

VL - 40

SP - 1843

EP - 1850

JO - The Annals of Pharmacotherapy

JF - The Annals of Pharmacotherapy

SN - 1060-0280

IS - 10

ER -